Literature DB >> 9231730

Metabotropic glutamate receptor subtype mGluR1alpha stimulates the secretion of the amyloid beta-protein precursor ectodomain.

R M Nitsch1, A Deng, R J Wurtman, J H Growdon.   

Abstract

To examine the effects of glutamatergic neurotransmission on amyloid processing, we stably expressed the metabotropic glutamate receptor subtype 1alpha (mGlu-R1alpha) in HEK 293 cells. Both glutamate and the selective metabotropic agonist 1-amino-1,3-cyclopentanedicarboxylic acid (ACPD) rapidly increased phosphatidylinositol (PI) turnover four- to fivefold compared with control cells that were transfected with the expression vector alone. Increased PI turnover was effectively blocked by the metabotropic antagonist alpha-methyl-4-carbophenylglycine (MCPG), indicating that heterologous expression of mGluR1alpha resulted in efficient coupling of the receptors to G protein and phospholipase C activation. Stimulation of mGluR1alpha with glutamate, quisqualate, or ACPD rapidly increased secretion of the APP ectodomain (APPs); these effects were blocked by MCPG. The metabotropic receptors were coupled to APP processing by protein kinases and by phospholipase A2 (PLA2), and melittin, a peptide that stimulates PLA2, potently increased APPs secretion. These data indicate that mGluR1alpha can be involved in the regulation of APP processing. Together with previous findings that muscarinic and serotonergic receptor subtypes can increase the secretion of the APP ectodomain, these observations support the concept that proteolytic processing of APP is under the control of several major neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231730     DOI: 10.1046/j.1471-4159.1997.69020704.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

Authors:  H Meziane; J C Dodart; C Mathis; S Little; J Clemens; S M Paul; A Ungerer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

2.  Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease.

Authors:  R M Nitsch; C Kim; J H Growdon
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression.

Authors:  Y Li; L Liu; J Kang; J G Sheng; S W Barger; R E Mrak; W S Griffin
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 4.  P2Y2 nucleotide receptor-mediated responses in brain cells.

Authors:  Troy S Peterson; Jean M Camden; Yanfang Wang; Cheikh I Seye; W G Wood; Grace Y Sun; Laurie Erb; Michael J Petris; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2010-04-13       Impact factor: 5.590

5.  Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats.

Authors:  E L Schaeffer; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

6.  Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 7.  The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease.

Authors:  Vicky W-W Tsai; Heather L Scott; Richard J Lewis; Peter R Dodd
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 8.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

9.  Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor.

Authors:  Qiongman Kong; Troy S Peterson; Olga Baker; Emily Stanley; Jean Camden; Cheikh I Seye; Laurie Erb; Agnes Simonyi; W Gibson Wood; Grace Y Sun; Gary A Weisman
Journal:  J Neurochem       Date:  2009-03-20       Impact factor: 5.372

Review 10.  Signal transduction therapeutics: relevance for Alzheimer's disease.

Authors:  Odete A B da Cruz e Silva; Margarida Fardilha; Ana Gabriela Henriques; Sandra Rebelo; Sandra Vieira; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.